Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Nomura: Rising caution over currency market intervention limits USD/JPY gains

Nomura: Rising caution over currency market intervention limits USD/JPY gains

金色财经金色财经2026/06/29 07:25
Show original
```htmlJinse Finance reported that on June 29, four analysts from the Nomura Global FX Strategy team stated in a research report that the rise of USD/JPY remains limited due to increased vigilance regarding Japanese authorities intervening in the foreign exchange market. They commented: "Based on previous intervention events, though we note the sample size is extremely limited, we observe that as USD/JPY approaches the 163 level, the likelihood of intervention by Japan’s Ministry of Finance grows." These analysts estimated the 163 level using data from two rounds of yen-buying interventions in 2022 and 2024 within the same year. According to data from the London Stock Exchange Group, the US dollar was essentially flat, quoted at 161.79 yen.```
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The 160 Threshold Under Threat Again! Yen Nears "Intervention Red Line," Tokyo May Spend Money Again to Rescue the Currency

The Japanese yen is approaching the 1 USD = 160 JPY level. Atsushi Mimura commented that the movement is "too fast." The US-Japan interest rate gap may widen further, and Japanese officials have hinted at being ready to intervene again.

智通财经•2026/11/12 02:26

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07